PQQ: Effect on Growth, Reproduction, Immune Function, and Extracellular Matrix Maturation in Mice

Author(s):  
Francene M. Steinberg ◽  
Carsten Smidt ◽  
Jack Kilgore ◽  
Nadia Romero-Chapman ◽  
David Tran ◽  
...  
2010 ◽  
Vol 18 ◽  
pp. S225
Author(s):  
R. Wilson ◽  
A. Diseberg ◽  
S. Zivkovic ◽  
L. Gordon ◽  
L. Tatarczuch ◽  
...  

1991 ◽  
Vol 2 (3) ◽  
pp. 369-387 ◽  
Author(s):  
Adele L. Boskey

The extracellular matrix of dentin consists of mineral (hydroxyapatite), collagen, and several noncollagenous matrix proteins. These noncollagenous matrix proteins may be mediators of cell-matrix interactions, matrix maturation, and mineralization. This review describes the current knowledge of the chemistry of mineral crystal formation in dentin with special emphasis on the roles of the dentin matrix proteins. The functions of some of these matrix proteins in the mineralization process have been deduced based on in vitro studies. Functions for others have been postulated based on analogy with some of the bone matrix proteins. Evidence suggests that several of these matrix proteins may have multiple effects on nucleation, crystal growth, and orientation of dentin hydroxyapatite.


Author(s):  
Wayne Carver ◽  
Louis Terracio ◽  
Thomas K. Borg

Cancers ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3331
Author(s):  
Alex Gordon-Weeks ◽  
Arseniy Yuzhalin

The extracellular matrix (ECM) plays an increasingly recognised role in the development and progression of cancer. Whilst significant progress has been made in targeting aspects of the tumour microenvironment such as tumour immunity and angiogenesis, there are no therapies that address the cancer ECM. Importantly, immune function relies heavily on the structure, physics and composition of the ECM, indicating that cancer ECM and immunity are mechanistically inseparable. In this review we highlight mechanisms by which the ECM shapes tumour immunity, identifying potential therapeutic targets within the ECM. These data indicate that to fully realise the potential of cancer immunotherapy, the cancer ECM requires simultaneous consideration.


2003 ◽  
Vol 59 (1) ◽  
pp. 1-9 ◽  
Author(s):  
Daniel A Martinez ◽  
David J Guhl ◽  
William C Stanley ◽  
Arthur C Vailas

Sign in / Sign up

Export Citation Format

Share Document